ATE517121T1 - Integrin-heterodimer und eine alpha-untereinheit davon - Google Patents

Integrin-heterodimer und eine alpha-untereinheit davon

Info

Publication number
ATE517121T1
ATE517121T1 AT00939232T AT00939232T ATE517121T1 AT E517121 T1 ATE517121 T1 AT E517121T1 AT 00939232 T AT00939232 T AT 00939232T AT 00939232 T AT00939232 T AT 00939232T AT E517121 T1 ATE517121 T1 AT E517121T1
Authority
AT
Austria
Prior art keywords
subunit
integrin
alpha subunit
integrin heterodimer
marker
Prior art date
Application number
AT00939232T
Other languages
English (en)
Inventor
Donald Gullberg
Original Assignee
Cartela R & D Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20415884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE517121(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cartela R & D Ab filed Critical Cartela R & D Ab
Application granted granted Critical
Publication of ATE517121T1 publication Critical patent/ATE517121T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00939232T 1999-06-03 2000-05-31 Integrin-heterodimer und eine alpha-untereinheit davon ATE517121T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9902056A SE9902056D0 (sv) 1999-06-03 1999-06-03 An integrin heterodimer and an alpha subunit thereof
PCT/SE2000/001135 WO2000075187A1 (en) 1999-06-03 2000-05-31 An integrin heterodimer and an alpha subunit thereof

Publications (1)

Publication Number Publication Date
ATE517121T1 true ATE517121T1 (de) 2011-08-15

Family

ID=20415884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00939232T ATE517121T1 (de) 1999-06-03 2000-05-31 Integrin-heterodimer und eine alpha-untereinheit davon

Country Status (8)

Country Link
US (3) US7485429B1 (de)
EP (1) EP1181317B1 (de)
JP (2) JP2003501077A (de)
AT (1) ATE517121T1 (de)
AU (1) AU770652B2 (de)
CA (1) CA2375876A1 (de)
SE (1) SE9902056D0 (de)
WO (1) WO2000075187A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055231A1 (en) 1998-10-28 2003-03-20 Jian Ni 12 human secreted proteins
US7622437B2 (en) 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
US7083958B2 (en) 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
CN1474831A (zh) 2000-11-20 2004-02-11 ����ŵ˹������ѧ�йܻ� 膜支架蛋白
US7592008B2 (en) 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
US6858395B2 (en) 2001-02-20 2005-02-22 The Board Of Trustees Of The University Of Illinois Diagnostics assay methods and amelioration of muscular dystrophy symptoms
AU2003239016B2 (en) * 2002-06-14 2007-09-20 Xintela Ab Marker for stem cells and its use
WO2008068481A1 (en) * 2006-12-05 2008-06-12 Cartela R & D Ab New compounds, methods and uses
WO2008075038A1 (en) * 2006-12-18 2008-06-26 Bioinvent International Ab Binding agents to the integrin alpha-11 subunit
CA2709411A1 (en) * 2006-12-18 2008-06-26 Cartela R&D Ab Binding agents to the integrin alpha-11 subunit, and uses thereof
PH12022551471A1 (en) * 2019-12-20 2023-04-24 Momenta Pharmaceuticals Inc Antibodies against integrin alpha 11 beta 1

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
DE68929402T2 (de) * 1988-12-22 2002-12-05 Genentech, Inc. Verfahren zur herstellung von wasserlöslichen polypeptiden
US5310874A (en) 1991-05-03 1994-05-10 The Scripps Research Institute Integrin α subunit cytoplasmic domain polypeptides and antibodies
US5304603A (en) * 1991-06-18 1994-04-19 The Population Council Leydig cell stimulator
GB9122820D0 (en) * 1991-10-28 1991-12-11 Wellcome Found Stabilised antibodies
EP0635029A4 (de) * 1992-04-10 1996-01-24 Gen Hospital Corp Matrixprotein aus knorpel und anwendungsmethoden.
US5840299A (en) 1994-01-25 1998-11-24 Athena Neurosciences, Inc. Humanized antibodies against leukocyte adhesion molecule VLA-4
US5968770A (en) * 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
NZ335932A (en) * 1996-11-21 2001-03-30 Cor Therapeutics Inc Use of a peptide agent such as a diphosphorylated peptide to modulate the interactions between myosin and integrins
US7368531B2 (en) 1997-03-07 2008-05-06 Human Genome Sciences, Inc. Human secreted proteins
US20060122373A1 (en) 1997-04-04 2006-06-08 Millennium Pharmaceuticals, Inc. Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof
US6046316A (en) * 1997-12-09 2000-04-04 Wayne State University Nucleic acid encoding truncated integrins
DK1068238T3 (da) * 1998-04-02 2013-01-14 Xintela Ab Integrinheterodimer og subunit deraf
AU1231400A (en) * 1998-10-28 2000-06-05 Human Genome Sciences, Inc. 12 human secreted proteins
US20030055231A1 (en) 1998-10-28 2003-03-20 Jian Ni 12 human secreted proteins
US20030129685A1 (en) 1998-10-28 2003-07-10 Jian Ni 12 human secreted proteins
EP1187851A1 (de) 1999-05-28 2002-03-20 Millennium Pharmaceuticals, Inc. Neue integrin alpha-untereinheit und deren verwendungen
EP1534331B1 (de) 2002-06-21 2014-10-29 Johns Hopkins University School of Medicine Membran-assoziierte tumorendothel-marker
US7294290B2 (en) * 2003-08-01 2007-11-13 Ngx, Inc. Photochromic composition in a solid matrix

Also Published As

Publication number Publication date
US20120114708A1 (en) 2012-05-10
JP2003501077A (ja) 2003-01-14
JP2006246894A (ja) 2006-09-21
CA2375876A1 (en) 2000-12-14
US7485429B1 (en) 2009-02-03
US20090185979A1 (en) 2009-07-23
WO2000075187A1 (en) 2000-12-14
EP1181317A1 (de) 2002-02-27
EP1181317B1 (de) 2011-07-20
AU5435500A (en) 2000-12-28
AU770652B2 (en) 2004-02-26
SE9902056D0 (sv) 1999-06-03

Similar Documents

Publication Publication Date Title
LTC1131065I2 (lt) Dialkilfumaratai, skirti autoimuninėms ligoms gydyti
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
MXPA02006679A (es) Composicion farmaceutica.
NO170194C (no) Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer
GEP20022804B (en) Erythropoietin Derivatives
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
ATE279938T1 (de) Reduktion des gewebe-volumens
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
SE8804629D0 (sv) New therapeutically active compounds
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
NO20016304L (no) Erytropoetinkonjugater med polyetylenglykol, fremstilling av slike konjugater, preparater omfattende slike konjugater samt anvendelse av slike konjugater for fremstilling av medikamenter for forebygging eller behandling av sykdom
TR200401603T4 (tr) D vitamini benzerleri
ATE187740T1 (de) Modifizierte proteine und peptide enthaltende pharmazeutische mittel
ATE286057T1 (de) Pharmazeutische zubereitungen enthaltend clavulansäure
HUP0301349A2 (hu) IL-11-tartalmú készítmények
SE9902056D0 (sv) An integrin heterodimer and an alpha subunit thereof
NO20013517L (no) Makrolider med anti-inflammatorisk aktivitet
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
HUP9800635A2 (hu) In vivo exogén transzfekcióra és expresszióra használható gyógyászati kombináció
PA8449301A1 (es) Composiciones farmaceuticas
SE0001916D0 (sv) Novel formulation
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
DE60036199D1 (de) Proteaseresistente flint-analoge
ATE210991T1 (de) Zusammensetzung auf der basis von pflanzenextrakten und ätherischen ölen, verwendbar in therapeutika, kosmetika und diätnahrung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties